Literature DB >> 16756626

Incidence and risk factors for the development of acute renal failure in patients with ventilator-associated pneumonia.

Gul Gursel1, Nalan Demir.   

Abstract

AIM: Infections are one of the most important risk factors for the development of acute renal failure (ARF) and ventilator-associated pneumonia (VAP) has been reported as one of the most frequent infection in intensive care units (ICU). Sepsis, shock, multiorgan dysfunction syndrome (MODS), use of nephrotoxic antibiotics and mechanical ventilation are potential risk factors for development of ARF during VAP. The objective of the study was to evaluate the incidence of ARF in patients with VAP and the role of VAP-related potential risk factors in the development of ARF.
METHODS: One hundred and eight patients who were admitted to the pulmonary ICU of a university hospital and developed VAP were included in this prospective observational cohort study. Only first episodes of VAP were studied. Diagnosis was based on microbiologically confirmed clinical findings. Potential outcome variables including responsible pathogens, recurrence, polymicrobial aetiology, bacteraemia, multidrug resistance of microorganisms, late/early VAP and sepsis and other known risk factors for development of ARF were evaluated. Risk factors were analysed by logistic regression analysis for significance.
RESULTS: Incidence of ARF was 38% (n = 41). Pneumonia with multidrug resistant pathogens (odds ratio, (OR) 5; 95% confidence interval (95%CI), 1.5-18; P = 0.011), sepsis (OR, 5.6; 95%CI, 1.7-18; P = 0.005) and severity of admission disease (Acute Physiology and Chronic Health Evaluation II score: OR, 1.1; 95%CI, 1.02-1.3; P = 0.017) were independent risk factors for the development of ARF during VAP episodes in multivariate analysis.
CONCLUSION: These results showed that the incidence of ARF is high during the VAP episodes and that VAP developed with multidrug resistant pathogens and sepsis have an independent effect on the development of ARF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756626     DOI: 10.1111/j.1440-1797.2006.00567.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  5 in total

1.  Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.

Authors:  M E Eichhorn; H Wolf; H Küchenhoff; M Joka; K-W Jauch; W H Hartl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

2.  Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies.

Authors:  Samuel E Wilson; Donald R Graham; Whedy Wang; Jon B Bruss; Bibiana Castaneda-Ruiz
Journal:  Infect Dis Ther       Date:  2017-07-10

3.  Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.

Authors:  Ah Young Leem; Moo Suk Park; Byung Hoon Park; Won Jai Jung; Kyung Soo Chung; Song Yee Kim; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Joon Chang; Joo Han Song
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

4.  Factors Predictive of Ventilator-associated Pneumonia in Critically Ill Trauma Patients.

Authors:  Duraid Younan; Sarah J Delozier; John Adamski; Andrew Loudon; Aisha Violette; Jeffrey Ustin; Glen Tinkoff; Matthew L Moorman; Nathaniel McQuay
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

5.  Fluid Overload and Kidney Injury Score as a Predictor for Ventilator-Associated Events.

Authors:  Jarin Vaewpanich; Ayse Akcan-Arikan; Jorge A Coss-Bu; Curtis E Kennedy; Jeffrey R Starke; Satid Thammasitboon
Journal:  Front Pediatr       Date:  2019-05-22       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.